A new study suggests that an epilepsy drug could help alleviate symptoms of obstructive sleep apnoea, a common condition affecting about 5% of people. Presented at the European Respiratory Society Congress in Vienna, the research indicates that the drug sulthiame may significantly reduce breathing interruptions and improve oxygen levels during sleep. Obstructive sleep apnoea, which causes frequent interruptions in breathing during sleep, is often treated with mechanical devices like CPAP machines. However, many patients struggle with these devices, prompting the search for alternative treatments. The international study involved nearly 300 patients across Belgium, the Czech Republic, France, Germany, and Spain, who were either given sulthiame at varying doses or a placebo. After 12 weeks, those on sulthiame experienced up to 50% fewer breathing pauses and higher blood oxygen levels compared to those on the placebo. The most significant benefits were observed with the highest doses of the drug. Source: Oman News Agency
Related Articles
Gold Price Drops After US-Vietnam Trade Deal
Muscat: Gold prices declined today after a US-Vietnam trade deal eased tensions, while investors awaited the US payroll data later in the day for clues about the Federal Reserve’s policy path.
According to Oman News Agency, spot gold lost 0.3% to $…
Gold Prices Rise on Hopes of US Interest Rate Cut
Gold prices went up today amid expectations of a US rate cut in September and rising geopolitical tensions in the Middle East.
Spot gold was up 0.5% at $2,397.65 per ounce. US gold futures climbed 0.7% to $2,396.70.
The US central bank’s Federal Ope…
Oman Food Capital Signs Strategic Partnership with Brazil’s JBS
Muscat: Oman Food Capital, a subsidiary of Oman Investment Authority (OIA), has signed a strategic partnership with Brazil’s JBS, one of the world’s largest food companies. The partnership will see JBS operate new facilities in the Sultanate of Oman f…
